How new drugs may change the standard of care for CLL
Follow-up results of looking at treatment with ibrutinib on CLL patient survival and adverse events
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
Impressive results from phase 3 RESONATE trial in CLL
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus